Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AN OPEN STUDY OF LAMIVUDINE TREATMENT IN ADULT HBeAg NEGATIVE (Presumed Pre-core Mutant) CHRONIC HEPATITIS B PATIENTS IN IRAN.

NCT00354653 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT00354653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00354653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AN OPEN STUDY OF LAMIVUDINE TREATMENT IN ADULT HBeAg NEGATIVE (Presumed Pre-core Mutant) CHRONIC HEPATITIS B PATIENTS IN IRAN.
Lead sponsor
ViiV Healthcare
Phase
Phase 4
Overall status
Completed
Start date
February 9, 2002
Completion date
January 23, 2007
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b